“[This will] enhance the delivery of care by doctors [and] will speed up the diagnosis of heart conditions for the public,” he explains.
IHH Healthcare – a Singapore Exchange and Bursa Malaysia-listed healthcare operator – and investment company Heal Partners are leading a US$15 million ($20.3 million) series A round in medtech start-up Us2.ai.
IHH Healthcare CEO Kelvin Loh says that the company is looking to support and make cutting-edge clinical tools and care more accessible and affordable for patients, through its investments in digital health companies like Us2.ai.
